Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koray Tascilar

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
The Lancet Regional Health. Europe|December 20, 2023
Why has the incidence of heart failure decreased by half in Türkiye?Koray Tascilar
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2025
On observing the standards of descriptive epidemiology: Comment on the article by Ozturk et alKoray Tascilar
Multiple Sclerosis and Related Disorders|April 22, 2025
Incomparable regional prevalence estimates of Neuromyelitis Optica due to lack of standardization: Comment on the article by Taskiran et.alAlp Temiz, Koray Tascilar
Current Opinion in Immunology|April 9, 2026
Why we need to maintain a critical view on big data and artificial intelligence predictionsAlp Temiz, Koray Tascilar
Arthritis & Rheumatology (Hoboken, N.J.)|March 28, 2022
On the perils of peeking into the future: comment on the article by Rosenthal et alMelek Yalcin Mutlu, Koray Tascilar
The Lancet. Rheumatology|January 24, 2024
Subclinical synovitis: let's discuss prognosis before treatmentMelek Yalcin-Mutlu, Koray Tascilar
Current Opinion in Rheumatology|November 16, 2022
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria sets for three types of antineutrophilic cytoplasmic antibody-associated vasculitisHasan Yazici, Koray Tascilar, Yusuf Yazici
Nature Reviews. Rheumatology|April 16, 2016
Comparative effectiveness research with administrative health data in rheumatoid arthritisMarie Hudson, Koray Tascilar, Samy Suissa
Arthritis and Rheumatism|March 20, 2013
Neoplasms as the leading cause of death among patients with rheumatoid arthritis receiving tumor necrosis factor inhibitors: comment on the article by Simard et alHasan Yazici, Koray Tascilar, Yusuf Yazici
Current Opinion in Immunology|April 18, 2026
A critical look at observational studiesMurat Torgutalp, Didem Sahin, Koray Tascilar
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
The Lancet Regional Health. Europe|December 20, 2023
Why has the incidence of heart failure decreased by half in Türkiye?Koray Tascilar
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2025
On observing the standards of descriptive epidemiology: Comment on the article by Ozturk et alKoray Tascilar
Multiple Sclerosis and Related Disorders|April 22, 2025
Incomparable regional prevalence estimates of Neuromyelitis Optica due to lack of standardization: Comment on the article by Taskiran et.alAlp Temiz, Koray Tascilar
Current Opinion in Immunology|April 9, 2026
Why we need to maintain a critical view on big data and artificial intelligence predictionsAlp Temiz, Koray Tascilar
Arthritis & Rheumatology (Hoboken, N.J.)|March 28, 2022
On the perils of peeking into the future: comment on the article by Rosenthal et alMelek Yalcin Mutlu, Koray Tascilar
The Lancet. Rheumatology|January 24, 2024
Subclinical synovitis: let's discuss prognosis before treatmentMelek Yalcin-Mutlu, Koray Tascilar
Current Opinion in Rheumatology|November 16, 2022
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria sets for three types of antineutrophilic cytoplasmic antibody-associated vasculitisHasan Yazici, Koray Tascilar, Yusuf Yazici
Nature Reviews. Rheumatology|April 16, 2016
Comparative effectiveness research with administrative health data in rheumatoid arthritisMarie Hudson, Koray Tascilar, Samy Suissa
Arthritis and Rheumatism|March 20, 2013
Neoplasms as the leading cause of death among patients with rheumatoid arthritis receiving tumor necrosis factor inhibitors: comment on the article by Simard et alHasan Yazici, Koray Tascilar, Yusuf Yazici
Current Opinion in Immunology|April 18, 2026
A critical look at observational studiesMurat Torgutalp, Didem Sahin, Koray Tascilar
Pageof 12